Legend Biotech Corporation American Depositary Shares (LEGN) — Analysis Summary
Legend Biotech Corporation American Depositary Shares (LEGN) has a market cap of $4.36B with year-over-year revenue growth of +120.0%. Net margin stands at -28.2%. The stock trades at a P/E ratio of -24.6.
Key Takeaways
- Revenue changed +120.0% year-over-year
- Net margin of -28.2%
- P/E ratio of -24.6
LEGN posted revenue growth of +120.0% and trades at a P/E of -24.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.